Non‐genetic factors associated with ACE‐inhibitor and angiotensin receptor blocker‐induced angioedema
Clinical and Translational Allergy2025Vol. 15(5), pp. e70058–e70058
Citations Over TimeTop 10% of 2025 papers
Diana Dubrall, Nora L. Branding, Carina M. Mathey, Anna Weber, Michael Steffens, Maike Below, Matthias Schmid, Bettina Wedi, D. Wieczorek, Philipp M. Amann, H. Löffler, Lukas Koch, Clemens Schöffl, Heinrich Dickel, Nomun Ganjuur, Thorsten Hornung, Timo Buhl, Emel Aygören‐Pürsün, Gerda Wurpts, Jens Greve, Markus M. Nöthen, Andreas J. Forstner, Bernhardt Sachs
Abstract
We found small to moderate associations with certain individual patient-related factors in this pharmaco-epidemiological study. As a future perspective, combining non-genetic association factors with corresponding genetic data might provide an option to compose stronger and individual risk scores.
Related Papers
- → Angioedema due to angiotensin-converting enzyme inhibitors(1999)146 cited
- → Angiotensin-converting-enzyme inhibitor–induced angioedema(2021)7 cited
- → Studies of the mechanism of angiotensin-converting enzyme (ACE) inhibitor-associated angioedema: The effect of an ACE inhibitor on cutaneous responses to bradykinin, codeine, and histamine(1990)81 cited
- → Angiotensin II Receptor Blockers in Patients with ACE Inhibitor–Induced Angioedema(2000)7 cited
- [Life-threatening angioedema as a side effect of angiotensin-converting-enzyme (ACE) inhibitors].(1995)